Search Results - "Parkinson's disease"

Refine Results
  1. 1

    Plasma Prolidase Activity and Oxidative Stress in Patients with Parkinson's Disease by Srivastava, Shalabh, Singh, Tej Bali, Sharma, Vivek, Raj, Janak, Verma, Akhilesh Kumar, Srivastava, Ragini

    Published in Parkinson's disease (01-01-2015)
    “…Prolidase deficiency has been related to mental retardation and oxidative stress. The study aimed to observe plasma prolidase activity (PPA), total oxidant…”
    Get full text
    Journal Article
  2. 2

    Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation by Tamburin, Stefano, Smania, Nicola, Roncari, Laura, Federico, Angela, Tocco, Pierluigi, Picelli, Alessandro, Magrinelli, Francesca, Zanette, Giampietro

    Published in Parkinson's disease (01-01-2016)
    “…Cardinal motor features of Parkinson’s disease (PD) include bradykinesia, rest tremor, and rigidity, which appear in the early stages of the disease and…”
    Get full text
    Journal Article
  3. 3

    Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application by Xu, Lingjia, Pu, Jiali

    Published in Parkinson's disease (01-01-2016)
    “…Parkinson’s disease is a neurodegenerative disease/synucleinopathy that develops slowly; however, there is no efficient method of early diagnosis, nor is there…”
    Get full text
    Journal Article
  4. 4

    Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment by Dong, Huimin, Mao, Shanping, Lv, Longqin, Fang, Congcong, Liu, Baohui

    Published in Parkinson's disease (2020)
    “…Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder mainly in middle-elderly population, which represents diverse…”
    Get full text
    Journal Article
  5. 5

    The Synucleinopathies: Twenty Years On by Goedert, Michel, Jakes, Ross, Spillantini, Maria Grazia

    Published in Journal of Parkinson's disease (01-01-2017)
    “…In 2017, it is two hundred years since James Parkinson provided the first complete clinical description of the disease named after him, fifty years since the…”
    Get more information
    Journal Article
  6. 6

    Recurrent Falls in Parkinson’s Disease: A Systematic Review by Allen, Natalie E., Canning, Colleen G., Schwarzel, Allison K.

    Published in Parkinson's disease (01-01-2013)
    “…Most people with Parkinson’s disease (PD) fall and many experience recurrent falls. The aim of this review was to examine the scope of recurrent falls and to…”
    Get full text
    Journal Article
  7. 7

    The Synaptic Function of α-Synuclein by Burré, Jacqueline

    Published in Journal of Parkinson's disease (08-10-2015)
    “…α-Synuclein is an abundant neuronal protein which localizes predominantly to presynaptic terminals, and is strongly linked genetically and pathologically to…”
    Get more information
    Journal Article
  8. 8
  9. 9

    The role of oxidative stress in Parkinson's disease by Dias, Vera, Junn, Eunsung, Mouradian, M Maral

    Published in Journal of Parkinson's disease (2013)
    “…Oxidative stress plays an important role in the degeneration of dopaminergic neurons in Parkinson's disease (PD). Disruptions in the physiologic maintenance of…”
    Get more information
    Journal Article
  10. 10

    Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation by Romano, Stefano, Savva, George M., Bedarf, Janis R., Charles, Ian G., Hildebrand, Falk, Narbad, Arjan

    Published in NPJ Parkinson's Disease (10-03-2021)
    “…The gut microbiota is emerging as an important modulator of neurodegenerative diseases, and accumulating evidence has linked gut microbes to Parkinson’s…”
    Get full text
    Journal Article
  11. 11

    Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff by Braak, Heiko, Del Tredici, Kelly

    Published in Journal of Parkinson's disease (01-01-2017)
    “…A relatively small number of especially susceptible nerve cell types within multiple neurotransmitter systems of the human central, peripheral, and enteric…”
    Get more information
    Journal Article
  12. 12

    A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications by Kelly, Valerie E., Eusterbrock, Alexis J., Shumway-Cook, Anne

    Published in Parkinson's disease (2012)
    “…Gait impairments in Parkinson's disease (PD) are exacerbated under dual-task conditions requiring the simultaneous performance of cognitive or motor tasks…”
    Get full text
    Journal Article
  13. 13

    Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future by Tan, Yu-Yan, Jenner, Peter, Chen, Sheng-Di

    Published in Journal of Parkinson's disease (01-01-2022)
    “…Monoamine oxidase-B (MAO-B) inhibitors are commonly used for the symptomatic treatment of Parkinson's disease (PD). MAO-B inhibitor monotherapy has been shown…”
    Get more information
    Journal Article
  14. 14

    The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease by Zhang, Cheng-wu, Lim, Kah-Leong, Liu, Chao, Xie, Xiaoji, Weng, Minrui, Li, Lin

    Published in Parkinson's disease (01-01-2018)
    “…Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by progressive loss of dopaminergic neurons in the substantia…”
    Get full text
    Journal Article
  15. 15

    Prevalence of Parkinson’s disease across North America by Marras, C., Beck, J. C., Bower, J. H., Roberts, E., Ritz, B, Ross, G. W., Abbott, R. D., Savica, R., Van Den Eeden, S. K., Willis, A. W., Tanner, CM

    Published in NPJ Parkinson's Disease (10-07-2018)
    “…Estimates of the prevalence of Parkinson’s disease in North America have varied widely and many estimates are based on small numbers of cases and from small…”
    Get full text
    Journal Article
  16. 16

    Current and projected future economic burden of Parkinson’s disease in the U.S by Yang, Wenya, Hamilton, Jamie L., Kopil, Catherine, Beck, James C., Tanner, Caroline M., Albin, Roger L., Ray Dorsey, E., Dahodwala, Nabila, Cintina, Inna, Hogan, Paul, Thompson, Ted

    Published in NPJ Parkinson's Disease (09-07-2020)
    “…Parkinson’s disease (PD) is one of the world’s fastest growing neurological disorders. Much is unknown about PD-associated economic burdens in the United…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease by Galvagnion, Céline

    Published in Journal of Parkinson's disease (01-01-2017)
    “…α-synuclein is a small protein abundantly expressed in the brain and mainly located in synaptic terminals. The conversion of α-synuclein into oligomers and…”
    Get more information
    Journal Article
  19. 19

    Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade? by Oueslati, Abid

    Published in Journal of Parkinson's disease (30-03-2016)
    “…Abnormal accumulation of proteinaceous intraneuronal inclusions called Lewy bodies (LBs) is the neurpathological hallmark of Parkinson's disease (PD) and…”
    Get more information
    Journal Article
  20. 20

    Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments by Di Paolo, Thérèse, Morin, Nicolas, Côté, Mélissa, Aubé, Benoit, Poirier, Andrée-Anne, Soulet, Denis

    Published in Parkinson's disease (01-01-2016)
    “…A diagnosis of Parkinson’s disease is classically established after the manifestation of motor symptoms such as rigidity, bradykinesia, and tremor. However, a…”
    Get full text
    Journal Article